185 related articles for article (PubMed ID: 24175846)
1. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
[TBL] [Abstract][Full Text] [Related]
3. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Li C; Xiang X; Zhou Y
Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
[TBL] [Abstract][Full Text] [Related]
4. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
5. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
[TBL] [Abstract][Full Text] [Related]
7. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
8. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
9. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
10. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
[TBL] [Abstract][Full Text] [Related]
11. Association of Arg194Trp, Arg280His and Arg399Gln polymorphisms in X-ray repair cross-complementing group 1 gene and risk of differentiated thyroid carcinoma in Iran.
Fard-Esfahani P; Fard-Esfahani A; Fayaz S; Ghanbarzadeh B; Saidi P; Mohabati R; Bidoki SK; Majdi M
Iran Biomed J; 2011; 15(3):73-8. PubMed ID: 21987112
[TBL] [Abstract][Full Text] [Related]
12. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Zhao DY; Cheng L; Yu J; Shen H
Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
[TBL] [Abstract][Full Text] [Related]
13. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
Zhang H; Liu H; Jiang G
PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies.
Zhang XQ; Li L
Medicine (Baltimore); 2021 Dec; 100(50):e28030. PubMed ID: 34918657
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Hu Z; Hu X; Long J; Su L; Wei B
Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246
[TBL] [Abstract][Full Text] [Related]
18. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
[TBL] [Abstract][Full Text] [Related]
19. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
[TBL] [Abstract][Full Text] [Related]
20. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
Zhang H; Liu H; Knauss JL
Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]